Literature DB >> 17185080

Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus.

Ganapathy A Prasad1, Kenneth K Wang, Navtej S Buttar, Louis-Michel Wongkeesong, Lori S Lutzke, Lynn S Borkenhagen.   

Abstract

BACKGROUND: Stricture formation is the leading cause of long-term morbidity after photodynamic therapy (PDT). Risk factors for stricture formation have not been studied.
OBJECTIVE: To assess risk factors for stricture formation in patients undergoing PDT for Barrett's esophagus with high-grade dysplasia (HGD).
DESIGN: Retrospective cohort study.
SETTING: Barrett's Unit, Mayo Clinic, Rochester, Minnesota.
METHODS: Records of patients undergoing PDT for HGD were reviewed. Patients underwent PDT by using either bare cylindrical diffusing fibers (2.5-5.0 cm in length) or balloon diffusers with 5- to 7-cm windows. Univariate and multivariate logistic regression analyses were performed to assess risk factors for stricture formation. MAIN OUTCOME MEASUREMENT: Esophageal stricture formation.
RESULTS: Thirty-five of 131 patients (27%) developed strictures. On multivariate analysis, statistically significant predictors of stricture formation were the following: EMR before PDT was odds ratio (OR) 2.7, 95% confidence interval (CI) 1.13-6.59; a prior history of esophageal stricture was OR 2.7, 95% CI 1.15-6.47; and the number of PDT applications was OR 2.2, 95% CI 1.22-4.12. The OR for stricture formation in patients when centering balloons were used was 0.41, 95% CI 0.11-1.46, P = .168, indicating that centering balloons did not significantly decrease the risk of stricture formation. LIMITATIONS: Retrospective single-center study; small proportion of patients treated with centering balloons.
CONCLUSIONS: Risk factors for development of strictures after PDT included history of a prior esophageal stricture, performance of EMR before PDT, and more than 1 PDT application in 1 treatment session. The use of centering balloons was not associated with a statistically significant reduction in the risk of stricture formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17185080     DOI: 10.1016/j.gie.2006.04.028

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  27 in total

Review 1.  Endoscopic management of Barrett's esophagus: advances in endoscopic techniques.

Authors:  Ali Azarm; Ismet Lukolic; Meenal Shukla; Ronald Concha-Parra; Frank Gress
Journal:  Dig Dis Sci       Date:  2012-07-04       Impact factor: 3.199

Review 2.  Barrett esophagus: an update.

Authors:  Rami J Badreddine; Kenneth K Wang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-01       Impact factor: 46.802

3.  Endoscopic resection techniques and ablative therapies for Barrett's neoplasia.

Authors:  Jacobo Ortiz-Fernández-Sordo; Adolfo Parra-Blanco; Alejandro García-Varona; María Rodríguez-Peláez; Erika Madrigal-Hoyos; Irving Waxman; Luis Rodrigo
Journal:  World J Gastrointest Endosc       Date:  2011-09-16

4.  Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus.

Authors:  Ganapathy A Prasad; Kenneth K Wang; Navtej S Buttar; Louis-Michel Wongkeesong; Kausilia K Krishnadath; Francis C Nichols; Lori S Lutzke; Lynn S Borkenhagen
Journal:  Gastroenterology       Date:  2007-02-07       Impact factor: 22.682

5.  Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett's esophagus.

Authors:  Jason J Lewis; Joel H Rubenstein; Amit G Singal; B Joseph Elmunzer; Richard S Kwon; Cyrus R Piraka
Journal:  Gastrointest Endosc       Date:  2011-08-05       Impact factor: 9.427

6.  Metal stenting to resolve post-photodynamic therapy stricture in early esophageal cancer.

Authors:  Young Koog Cheon
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

7.  Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus.

Authors:  Rami J Badreddine; Ganapathy A Prasad; Kenneth K Wang; Louis M Wong Kee Song; Navtej S Buttar; Kelly T Dunagan; Lori S Lutzke; Lynn S Borkenhagen
Journal:  Gastrointest Endosc       Date:  2009-12-03       Impact factor: 9.427

Review 8.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

9.  Ablation is in the eye of the beholder.

Authors:  Kenneth K Wang
Journal:  Clin Gastroenterol Hepatol       Date:  2013-03-21       Impact factor: 11.382

10.  Barrett's esophagus: where do we stand?

Authors:  Majid A Al Madi
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.